GI 181771 structure
|
Common Name | GI 181771 | ||
|---|---|---|---|---|
| CAS Number | 305366-98-7 | Molecular Weight | 605.64000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C34H31N5O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GI 181771GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity. |
| Name | 3-[[(3S)-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity. |
|---|---|
| Related Catalog | |
| Target |
Target: Cholecystokinin 1 receptor[1] |
| References |
| Molecular Formula | C34H31N5O6 |
|---|---|
| Molecular Weight | 605.64000 |
| Exact Mass | 605.22700 |
| PSA | 142.85000 |
| LogP | 5.56250 |
| unii-6yf0shr37t |
| GI 181771 |